폐경기 관련 우울증의 평가와 치료
Diagnosis and Treatment of Menopause-related depression
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Recent Korean statistics show that a Korean woman can now expect to live until her mid-80s, which implies living at least one-third of her life after menopause. The menopausal transition is typically marked by intense hormonal fluctuations, accompanied by sleep disturbance, vasomotor symptoms (e.g., hot flashes, night sweats), increased risk for osteoporosis, cardiovascular disease, and developing depression as well as mood disturbances. These symptoms can affect a woman’s quality of life negatively. Therefore, a comprehensive understanding of the accurate detection and appropriate treatment of various menopause-related symptoms including depression in the menopausal transitions and postmenopause is mandatory. This review primarily focused on the current knowledge about the treatment of menopause-related depression.
Abstract
Recent Korean statistics show that a Korean woman can now expect to live until her mid-80s, which implies living at least one-third of her life after menopause. The menopausal transition is typically marked by intense hormonal fluctuations, accompanied by sleep disturbance, vasomotor symptoms (e.g., hot flashes, night sweats), increased risk for osteoporosis, cardiovascular disease, and developing depression as well as mood disturbances. These symptoms can affect a woman’s quality of life negatively. Therefore, a comprehensive understanding of the accurate detection and appropriate treatment of various menopause-related symptoms including depression in the menopausal transitions and postmenopause is mandatory. This review primarily focused on the current knowledge about the treatment of menopause-related depression.
참고문헌 (80)
- Avis NE, "A longitudinal analysis of women’s attitudes toward the menopause: results from the Massachusetts Women’s Health Study", Maturitas, 13, pp.65~79 (1991)
- Mitchell ES, "Symptom experiences of midlife women: observations from the Seattle midlife women’s health study", Maturitas, 25, pp.1~10 (1996)
- Steiner M, "Mood disorders associated with the menopause. in: Depression in Women", pp.48~59 (1998), Martin Dunitz
- Oldenhave A, "Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years old", Am J Obstet Gynecol, 168, pp.772~778 (1993)
- Soules MR, "Executive summary: stages of reproductive aging workshop", Climacteric, 76, pp.267~272 (2001)
- McKinlay SM, "The normal menopause transition", Maturitas, 14, pp.103~115 (1992)
- Burger HG, "Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women", J Clin Endocrinol Metab, 84, pp.4025~4030 (1999)
- Burger H, "Nomenclature and endocrinology of menopause and perimenopause", Expert Rev Neurotheapeutics, 7, pp.S35~S43 (2007)
- Metcalf MG, "Pituitary ovarian function in normal women during the menopausal transition", Clin Endocrinol, 14, pp.234~255 (1981)
- Schmidt PJ, "Menopause-related affective disorders: a justification for further study", Am J Psychaitry, 148, pp.844~852 (1991)
- Nelson H, "Management of menopause-related symptoms", Evid Rep Technol Asses (Summ), 120, pp.1~6 (2005)
- Roberts RE, "The Center for Epidemiologic Studies Depression Scale: its use in a community sample", Am J Psychiatry, 14, pp.41~46 (1983)
- Harlow BL, "Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cylces", Arch Gen Psychiatry, 56, pp.418~424 (1999)
- Dennerstein L, "Mood and the menopausal transition", J Nerv Ment Dis, 187, pp.685~691 (1999)
- Freeman E, "Associations of hormones and menopausal status with depressed mood in women with no history of depression", Arch Gen Psychiatry, 63, pp.375~382 (2006)
- Freeman EW, "Hormones and menopausal status as predictors of depression in women in transition to menopause", Arch Gen Psychiatry, 61, pp.62~70 (2004)
- Harlow BL, "Depression and its influence on reproductive endocrine and menstrual cycle markers associated with menopausal transition: the Harvard Study of Moods and Cycles", Arch Gen Psychiatry, 60, pp.29~36 (2003)
- Woods N, "Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women’s Health Study", Res Nurs Health, 20, pp.119~129 (1997)
- Bromberger JT, "Persistent mood symptoms in a multiethnic community cohort of pre-and perimenopausal women", Am J Epidemiol, 158, pp.347~356 (2003)
- Burt VK, "Perimenopuase and menopause. In: Concise Guide to Women’s Mental Health", pp.103~115 (1997), American Psychiatric Press
- Kessler RC, "Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence", J Affect Disord, 29, pp.85~96 (1993)
- Joffe H, "Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?", Biol Psychiatry, 44, pp.798~811 (1998)
- Richards M, "Premenstrual symptoms and perimenopausal depression", Am J Psychiatry, 163, pp.133~137 (2006)
- Bromberger JT, "A longitudinal study of the effects of pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged women", Psychol Aging, 11, pp.207~213 (1996)
- Schmidt PJ, "A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women", Am J Psychiatry, 161, pp.2238~2244 (2004)
- Cohen L, "Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles", Arch Gen Psychiatry, 63, pp.385~390 (2006)
- Stearns V, "New therapeutic approaches for hot flashes in women", J Support Oncol, 1, pp.11~21 (2003)
- Erlik Y, "Association of waking episodes with menopausal hot flushes", JAMA, 245, pp.1741~1744 (1981)
- Freedman RR, "Lack of sleep disturbance from menopausal hot flashes", Fertil Steril, 82, pp.138~144 (2004)
- Kronenberg F, "Hot flashes: epidemiology and physiology", Ann N Y Acad Sci, 592, pp.52~86 (1990)
- Joffe H, "Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care", Menopause, 9, pp.392~398 (2002)
- Rubinow DR, "Estrogen-serotonin interactions: implications for affective regulation", Biol Psychiatry, 44, pp.839~850 (1998)
- Jaszmann L, "The age of menopause in the Netherlands: the statistical analysis of a survey", Int J Fertil, 14, pp.106~117 (1969)
- Schmidt PJ, "Stressful life events, personal loses, and perimenopause-related depression", Arch Womens Ment Health, 7, pp.19~26 (2004)
- Dennerstein L, "Empty nest or revolving door? A prospective study of women’s quality of life in midlife during the phase of children leaving and re-entering the home", Psychol Med, 32, pp.545~550 (2002)
- Kaufert PA, "The Manitoba Project: a re-examination of the link between menopause and depression", Maturitas, 14, pp.143~155 (1992)
- Becker D, "Psychological distress around menopause", Psychosomatics, 42, pp.252~257 (2001)
- Avis NE, "A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women’s Health Study", Ann Epidemiol, pp.4L214~4L220 (1994)
- Woods NF, "Anticipating menopause: observations from the Seattle Midlife Women’s Health Study", Menopause, 6, pp.167~173 (1999)
- Joffe H, "Assessment and treatment of hot flushes and menopausal mood disturbance", Psychiatr Clin North Am, 26, pp.563~580 (2003)
- Morrison MF, "Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trail", Biol Psychiatry, 55, pp.406~412 (2004)
- Rasgon NL, "Estrogen-replacement therapy for depression", Am J Psychiatry, 158, pp.1738~ (2001)
- Soares CN, "Efficacy of estadiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial", Arch Gen Psychiatry, 58, pp.529~534 (2001)
- Schmidt PJ, "Estrogen replacement in menopausal transition-related depression: a preliminary report", Am J Obstet Gynecol, 183, pp.414~420 (2000)
- Cohen LS, "Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report", Am J Psychiatry, 160, pp.1519~1522 (2003)
- Soares CN, "The role of reproductive hormones in the management of depression during menopause", Drugs Aging, 20, pp.85~100 (2003)
- Odmark IS, "Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens", Climacteric, 7, pp.92~102 (2004)
- Writing Group for the Women’s Health Initiative Investigators, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
- Guay MP, "Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after WHI publication", Pharmacoepidemiol Drug Saf, 16, pp.17~27 (2007)
- Grady D, "Predictors of difficulty when discontinuing postmenopausal hormone therapy", Obstet Gynecol, 102, pp.1233~1239 (2003)
- Ockene JK, "symptom experience after discontinuing use of estrogen plus progestin", JAMA, 294, pp.183~193 (2005)
- Soares CN, "Paroxetine versus placebo for women in midlife after hormone therapy discontinuation", Am J Med, 121, pp.159~162 (2008)
- Joffe H, "An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy", J Womens Health Gend Based Med, 10, pp.999~1004 (2001)
- Soares CN, "Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms", J Clin Psychiatry, 64, pp.473~479 (2003)
- Soares CN, "Escitalopram versus ethinyl estradiol and norethidrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life", Menopause, 13, pp.780~786 (2006)
- Morgan ML, "Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study", J Clin Psychiatry, 66, pp.774~780 (2005)
- Dias RS, "Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study", Menopause, 13, pp.202~211 (2006)
- Joffe H, "Treatment of depression and menopause-related symptoms with the serotonin-norepiniphrine reuptake inhibitor duloxetine", J Clin Psychiatry, 68, pp.943~950 (2007)
- Kornstein SG, "Gender differences in treatment response to sertraline versus imipramine in chronic depression", Am J Psychiatry, 157, pp.1445~1452 (2000)
- Entsuah AR, "Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo", J Clin Psychiatry, 62, pp.869~877 (2001)
- Cassano P, "Antidepressant response and well-being in pre-, peri- and postmnopausal women with major depressive disorder treated with fluoxetine", Psychother Psychosom, 74, pp.362~365 (2005)
- Worthington JJ III, "Treatment of antidepressant-induced sexual dysfunction", Drugs Today (Barc), 39, pp.887~896 (2003)
- Dorsey CM, "Effect of zolpidem on sleep in women with perimenopausal and postmnopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study", Clin Ther, 26, pp.1578~1586 (2004)
- Cheng G, "Isoflavone treatment for acute menopausal symptoms", Menopause, 14(3), pp.468~473 (2007)
- Irvin JH, "The effects of relaxation response training on menopausal symptoms", J Psychosom Obstet Gynecol, 17, pp.202~207 (1996)
- Coope J, "Hormonal and non-hormonal interventions for menopausal symptoms", Maturitas, 23, pp.159~168 (1996)
- Bergstrom I, "Training or EPT in perimenopause on balance and flushes", Acta Obstet Gynecol Scand, 86, pp.467~472 (2007)
- Dennerstein L, "A prospective population-based study of menopausal symptoms", Obstet Gynecol, 96, pp.351~358 (2000)
- Harlow BL, "Association of medically treated depression and age at natural menopause", Am J Epidemiol, 141, pp.1170~1176 (1995)
- Woods NF, "Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle midlife women’s health study", Menopause, 15, pp.223~232 (2008)
- Walters V, "Stress, anxiety and depression: women’s accounts of their health problems", Soc Sci Med, 36, pp.393~402 (1993)
- Woods NF, "Patterns of depressed mood in midlife women: observations from the Seattle Midlife Women’s Health Study", Res Nurs Health, 19, pp.111~123 (1996)
- Matthews KA, "Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women", J Consult Clin Psychol, 58, pp.345~351 (1990)
- Amick BC 3rd, "Relationship of job strain and isostrain to healthy status a cohort of women in the United States", Scand J Work Environ Health, 24, pp.54~61 (1998)
- Cheung Y, "Association between psychosocial work characteristics and health functioning in American women: prospective study", BMJ, 320, pp.1432~1436 (2000)
- Hunter M, "Relationship between psychological symptoms, somatic complaints and menopausal status", Matuitas, 8, pp.217~228 (1986)
- Hunter M, "The South-East England longitudinal study of the climacteric and postmenopause", Maturitas, 14, pp.117~126 (1992)
- Dennerstein L, "Hormone therapy and affect", Maturitas, 1, pp.247~259 (1979)
- Baker A, "Sleep disruption and mood changes associated with menopause", J Psychosom Res, 43, pp.359~369 (1997)
- Freeman EW, "Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women", J Womens Health Gend Based Med, 10, pp.67~76 (2001)
